← Browse by Condition
Medical Condition

alcohol use disorder

Total Trials
18
Recruiting Now
18
Trial Phases
Phase 2, EARLY_Phase 1, Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for alcohol use disorder sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — alcohol use disorder Clinical Trials

How many clinical trials are currently recruiting for alcohol use disorder?
ClinicalMetric currently tracks 18 actively recruiting clinical trials for alcohol use disorder, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 18. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for alcohol use disorder?
alcohol use disorder research spans Phase 1 (2 trials), Phase 2 (3 trials), Phase 3 (3 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a alcohol use disorder clinical trial?
Eligibility criteria for alcohol use disorder trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1
2
Phase 2
3
Phase 3
3
Top Sponsors
Yale University 3 trials
Zealand University Hospital 2 trials
University of California, Los Angeles 1 trial
Rajesh Narendran 1 trial
Medical University of South Carolina 1 trial

Recruiting Clinical Trials

NCT06494891 Phase 2
Recruiting
Motivation for IV Alcohol Self-Administration in Humans
Enrollment
210 pts
Location
United States
Sponsor
University of California, Los ...
View Trial →
NCT07612631 EARLY_Phase 1
Recruiting
Imaging CRF X NOP Interactions in Alcohol Use Disorder
Enrollment
90 pts
Location
United States
Sponsor
Rajesh Narendran
View Trial →
NCT05674409
Recruiting
Brief Family Involved Treatment Telehealth
Enrollment
400 pts
Location
United States
Sponsor
Medical University of South Ca...
View Trial →
NCT06559995 Phase 2, Phase 3
Recruiting
Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use Disorder
Enrollment
30 pts
Location
United States
Sponsor
University of Pennsylvania
View Trial →
NCT06675539
Recruiting
Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
Enrollment
545 pts
Location
France
Sponsor
Etablissement Public de Santé ...
View Trial →
NCT06493773
Recruiting
Alcohol Misuse Treatment to Patients Newly Diagnosed With Alcohol-related Liver Disease: a Randomized Controlled Trial
Enrollment
221 pts
Location
Denmark
Sponsor
Zealand University Hospital
View Trial →
NCT07219953 Phase 3
Recruiting
A Study of Brenipatide in Participants With Alcohol Use Disorder
Enrollment
1,100 pts
Location
United States, Belgi...
Sponsor
Eli Lilly and Company
View Trial →
NCT06620276
Recruiting
ACT_for Alcohol Use Disorder and Depression
Enrollment
30 pts
Location
Canada
Sponsor
Centre hospitalier de l'Univer...
View Trial →
NCT06793488 EARLY_Phase 1
Recruiting
Anxiety During Abstinence in AUD
Enrollment
60 pts
Location
United States
Sponsor
Columbia University
View Trial →
NCT05838274
Recruiting
Acute Alcohol Response In Bipolar Disorder: a Longitudinal Alcohol Administration/fMRI Study
Enrollment
100 pts
Location
United States
Sponsor
University of Texas at Austin
View Trial →
NCT05855031
Recruiting
The Liver Care Trial
Enrollment
408 pts
Location
Denmark
Sponsor
Zealand University Hospital
View Trial →
NCT07216872
Recruiting
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)
Enrollment
186 pts
Location
United States, Israe...
Sponsor
Brainsway
View Trial →
NCT06878287
Recruiting
Bright Light Therapy During Residential Alcohol Withdrawal
Enrollment
100 pts
Location
France
Sponsor
Centre Hospitalier St Anne
View Trial →
NCT06371404
Recruiting
Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat
Enrollment
150 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT07056894
Recruiting
Effects of Action-Based Cognitive Remediation on Substance Misuse in Early Phase Psychosis
Enrollment
50 pts
Location
Canada
Sponsor
Nova Scotia Health Authority
View Trial →
NCT07232641
Recruiting
Impact of Federal and State Medications for Opioid Use Disorder (MOUD) Policy Changes During the Pandemic
Enrollment
185,810 pts
Location
United States
Sponsor
Boston University
View Trial →
NCT05781009 Phase 2
Recruiting
Pregnenolone for the Treatment of Alcohol Use Disorder
Enrollment
150 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT05827159 Phase 3
Recruiting
Emergency Department-Initiated Medications for Alcohol Use Disorder
Enrollment
240 pts
Location
United States
Sponsor
Yale University
View Trial →

Related Conditions

alcohol withdrawal (3) alcoholism (3) alcohol dependence (2) alcohol abuse (2) ketosis (1) addiction substance (1) liver diseases alcoholic (1) treatment adherence (1) liver disease alcohol related (1) depression major depressive disorder (1) bipolar disorder (1) alcohol drinking (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology